Applying Metabolomics to Understand the Aggressive Phenotype and Identify Novel Therapeutic Targets in Glioblastoma

por Ahmed, Kamran A., Chinnaiyan, Prakash
Publicado 2014

Stage IIA and IIB testicular seminoma treated post-orchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients

por Ahmed, Kamran A., Wilder, Richard B.
Publicado 2015

Miliary breast cancer brain metastasis: a rare and aggressive form of central nervous system metastasis

por Mills, Matthew N., Ahmed, Kamran A.
Publicado 2020

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer

por Ahmed, Kamran A., Barney, Brandon M., Davis, Brian J., Park, Sean S., Kwon, Eugene D., Olivier, Kenneth R.
Publicado 2013

The radiosensitivity index predicts for overall survival in glioblastoma

por Ahmed, Kamran A., Chinnaiyan, Prakash, Fulp, William J., Eschrich, Steven, Torres-Roca, Javier F., Caudell, Jimmy J.
Publicado 2015

Progress in Gene Therapy for Prostate Cancer

por Ahmed, Kamran A., Davis, Brian J., Wilson, Torrence M., Wiseman, Gregory A., Federspiel, Mark J., Morris, John C.
Publicado 2012

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’

por Ahmed, Kamran A, Davis, Brian J, Mynderse, Lance A, Slezak, Jeffrey M, Bergstralh, Eric J, Wilson, Torrence M, Choo, C Richard
Publicado 2014

Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions

por Liveringhouse, Casey L., Washington, Iman R., Diaz, Roberto, Jimenez, Rachel B., Harris, Eleanor E., Rabinovitch, Rachel, Woodward, Wendy A., Torres-Roca, Javier F., Ahmed, Kamran A.
Publicado 2021

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

por Ahmed, Kamran A., Grass, G. Daniel, Orman, Amber G., Liveringhouse, Casey, Montejo, Michael E., Soliman, Hatem H., Han, Heather S., Czerniecki, Brian J., Torres-Roca, Javier F., Diaz, Roberto
Publicado 2018

Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma

por Naghavi, Arash O., Gonzalez, Ricardo J., Scott, Jacob G., Kim, Youngchul, Abuodeh, Yazan A., Strom, Tobin J., Echevarria, Michelle, Mullinax, John E., Ahmed, Kamran A., Harrison, Louis B., Fernandez, Daniel C.
Publicado 2017

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization

por Abuodeh, Yazan, Naghavi, Arash O, Ahmed, Kamran A, Venkat, Puja S, Kim, Youngchul, Kis, Bela, Choi, Junsung, Biebel, Benjamin, Sweeney, Jennifer, Anaya, Daniel A, Kim, Richard, Malafa, Mokenge, Frakes, Jessica M, Hoffe, Sarah E, El-Haddad, Ghassan
Publicado 2016

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability()

por Alfonso, Juan C.L., Grass, G. Daniel, Welsh, Eric, Ahmed, Kamran A., Teer, Jamie K., Pilon-Thomas, Shari, Harrison, Louis B., Cleveland, John L., Mulé, James J., Eschrich, Steven A., Torres-Roca, Javier F., Enderling, Heiko
Publicado 2021

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

por Ahmed, Kamran A., Liveringhouse, Casey L., Mills, Matthew N., Figura, Nicholas B., Grass, G. Daniel, Washington, Iman R., Harris, Eleanor E., Czerniecki, Brian J., Blumencranz, Peter W., Eschrich, Steven A., Scott, Jacob G., Diaz, Roberto, Torres-Roca, Javier F.
Publicado 2019

Patient choice for high‐volume center radiation impacts head and neck cancer outcome

por Naghavi, Arash O., Echevarria, Michelle I., Strom, Tobin J., Abuodeh, Yazan A., Venkat, Puja S., Ahmed, Kamran A., Demetriou, Stephanie, Frakes, Jessica M., Kim, Youngchul, Kish, Julie A., Russell, Jeffery S., Otto, Kristen J., Chung, Christine H., Harrison, Louis B., Trotti, Andy, Caudell, Jimmy J.
Publicado 2018

Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment

por Asamoah, Francis Adumata, Yarney, Joel, Scott, Aba, Vanderpuye, Verna, Yuan, Zhigang, Fernandez, Daniel C., Montejo, Michael E., Agyeman, Mervin, Boateng, Samuel Ntiamoah, Anarfi, Kwabena, Aidoo, Charles, Shahzad, Mian M., Chern, Jing-Yi, Chon, Hye-Sook, Wenham, Robert M., Yamoah, Kosj, Ahmed, Kamran A.
Publicado 2020

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

por Mills, Matthew N., Walker, Chelsea, Thawani, Chetna, Naz, Afrin, Figura, Nicholas B., Kushchayev, Sergiy, Etame, Arnold, Yu, Hsiang-Hsuan Michael, Robinson, Timothy J., Liu, James, Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.
Publicado 2021

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

por Mills, Matthew N., Naz, Afrin, Thawani, Chetna, Walker, Chelsea, Figura, Nicholas B., Kushchayev, Sergiy, Oliver, Daniel E., Etame, Arnold B., Yu, Hsiang-Hsuan Michael, Robinson, Timothy J., Liu, James K. C., Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.
Publicado 2021

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study

por Ahmed, Kamran A., Kim, Youngchul, Arrington, John A., Kim, Sungjune, DeJesus, Michelle, Soyano, Aixa E., Armaghani, Avan J., Costa, Ricardo L.B., Khong, Hung T., Loftus, Loretta S., Rosa, Marilin, Caudell, Jimmy J., Diaz, Roberto, Robinson, Timothy J., Etame, Arnold B., Tran, Nam D., Sahebjam, Solmaz, Soliman, Hatem H., Czerniecki, Brian J., Forsyth, Peter A., Yu, H. Michael, Han, Hyo S.
Publicado 2021